Gardasil9

BIOLOGICAL4 trials

Sponsors

University of Alabama at Birmingham, Johns Hopkins University, Miriam Elfström, Boston Medical Center

Conditions

CIN 2/3Cervical CancerHPVHPV InfectionHPV-Related MalignancyHuman Papilloma VirusImmunization

Early Phase 1

Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old

Active, not recruitingNCT05329961

Boston Medical CenterHuman Papilloma Virus

Start: 2022-09-26End: 2028-12-01Updated: 2026-07-01

Phase 4

Postpartum HPV Vaccination

CompletedNCT03451071

University of Alabama at BirminghamHPV-Related Malignancy

Start: 2019-04-29End: 2020-12-30Updated: 2021-10-04

HPV Vaccination Study in Postpartum Women

CompletedNCT04274153

Johns Hopkins UniversityHPV, Human Papilloma Virus, Immunization

Start: 2020-08-03End: 2023-02-01Updated: 2023-08-29

Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

RecruitingNCT04910802

Miriam ElfströmCervical Cancer, CIN 2/3, HPV Infection

Start: 2021-05-03End: 2027-12-31Target: 150000Updated: 2021-09-16

Related Papers

Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer

Nature Communications2024-05-0135 citations

Immunogenicity of 2-Dose HPV Vaccine Series for Postpartum Women

JAMA Network Open2024-01-292 citations